Abstract
To investigate the mechanisms underlying the depressed sarcolemmal (SL) Na(+)-K(+)-ATPase activity in congestive heart failure (CHF), different isoforms and gene expression of Na(+)-K(+)-ATPase were examined in the failing left ventricle (LV) at 8 weeks after myocardial infarction (MI). In view of the increased activity of renin-angiotensin system (RAS) in CHF, these parameters were also studied after 5 weeks of treatment with enalapril (10 mg x kg-1 x day-1), an angiotensin-converting enzyme inhibitor, and losartan (20 mg.kg-1.day-1), an angiotensin II type 1 receptor antagonist, starting at 3 weeks after the coronary ligation in rats. The infarcted animals showed LV dysfunction and depressed SL Na(+)-K(+)-ATPase activity. Protein content and mRNA levels for Na(+)-K(+)-ATPase alpha2 isoform were decreased whereas those for Na(+)-K(+)-ATPase alpha3 isoform were increased in the failing LV. On the other hand, no significant changes were observed in protein content or mRNA levels for Na(+)-K(+)-ATPase alpha1 and beta1 isoforms. The treatment of infarcted animals with enalapril or losartan improved LV function and attenuated the depression in Na(+)-K(+)-ATPase alpha2 isoform as well as the increase in alpha3 isoform, at both the p...Continue Reading
References
Mar 1, 1992·The American Journal of Physiology·I M DixonN S Dhalla
Apr 1, 1992·British Journal of Pharmacology·W Linz, B A Schölkens
Jul 14, 1988·The New England Journal of Medicine·M A PfefferE Braunwald
Apr 1, 1994·Hypertension·P GohlkeT Unger
Mar 1, 1993·Circulation·M RuzickaF H Leenen
Oct 8, 1997·Journal of the American College of Cardiology·R M LangP I Chang
Oct 10, 1997·Journal of Hypertension·M FleschM Böhm
Jun 18, 1998·American Heart Journal·M K BaigM Gheorghiade
Aug 26, 1998·Cardiovascular Research·J F Ramírez-GilD Charlemagne
Aug 26, 1998·Journal of Molecular and Cellular Cardiology·S O SembO M Sejersted
Oct 9, 1998·Cardiovascular Research·G Hasenfuss
Mar 15, 2000·Journal of the American College of Cardiology·J N CohnN Sharpe
Aug 23, 2000·Life Sciences·K KatoN S Dhalla
Jul 9, 2002·Journal of Molecular and Cellular Cardiology·Jingwei WangNaranjan S Dhalla
May 24, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Adel B ElmoselhiNaranjan S Dhalla
Dec 17, 2003·Molecular and Cellular Biochemistry·Xiaobing GuoNaranjan S Dhalla
Oct 8, 2004·Biochimica Et Biophysica Acta·Jingwei WangNaranjan S Dhalla
Dec 4, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Qiming ShaoNaranjan S Dhalla
Jan 25, 2005·British Journal of Pharmacology·Harjot K SainiNaranjan S Dhalla
Feb 1, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Qiming ShaoNaranjan S Dhalla
May 17, 2006·Journal of Cardiovascular Pharmacology and Therapeutics·Naranjan S DhallaRamesh K Goyal
Sep 15, 2006·The Canadian Journal of Cardiology·Jarmila MachackovaNaranjan S Dhalla
Citations
Jul 2, 2011·Age·Leanne GrobanChristy S Carter
Oct 15, 2008·Cardiovascular Research·Naranjan S DhallaParamjit S Tappia
Jun 21, 2013·The Journal of Endocrinology·Milan ObradovicEsma R Isenovic
Feb 5, 2010·Canadian Journal of Physiology and Pharmacology·He-Gui WangYong-Sheng Ke
Jan 27, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Weihua ZhangNaranjan S Dhalla
Sep 6, 2012·Journal of Cellular and Molecular Medicine·Andrea BabickNaranjan S Dhalla
Apr 9, 2011·Postgraduate Medicine·Wangde Dai, Robert A Kloner
Jun 17, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·O S MichaelL A Olatunji